The mol-ecule of the title compound, C19H23N5O3, contains six-membered pyrimidine and five-membered imidazole rings merged into the essentially planar purine skeleton (r.m.s. deviation = 0.01 Å). In the crystal, pairs of N-H⋯N hydrogen bonds link mol-ecules into inversion dimers. The dimers are linked via C-H⋯O hydrogen bonds, forming double-stranded chains propagating along [001]. These chains are linked via C-H⋯π and parallel slipped π-π inter-actions [centroid-centroid distance = 3.467 (1) Å; slippage 0.519 Å], forming a three-dimensional network.

Department of Inorganic Chemistry Faculty of Science Palacký University 17 listopadu 12 CZ 771 46 Olomouc Czech Republic

Zobrazit více v PubMed

Agilent (2012). CrysAlis PRO Agilent Technologies Ltd, Yarnton, Oxfordshire, England.

Brandenburg, K. (2011). DIAMOND Crystal Impact GbR, Bonn, Germany.

Cremer, D. & Pople, J. A. (1975). J. Am. Chem. Soc. 97, 1354–1358.

Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. PubMed

Soriano-Garcia, M., Avellaneda, C. R. & Aguirre-Hernandez, G. (2003). Anal. Sci. 19, 1343–1344. PubMed

Szüčová, L., Spíchal, L., Doležal, K., Zatloukal, M., Greplová, J., Galuszka, P., Kryštof, V., Voller, J., Popa, I., Massino, F. J., Jørgensen, J. E. & Strnad, M. (2009). Bioorg. Med. Chem. 17, 1938–1947. PubMed

Taddei, D., Kilian, P., Slawin, A. M. Z. & Woollins, J. D. (2004). Org. Biomol. Chem. 2, 665–670. PubMed

Westrip, S. P. (2010). J. Appl. Cryst. 43, 920–925.

N-(2-Meth-oxy-benz-yl)-9-(oxolan-2-yl)-9H-purin-6-amine